-
1
-
-
42149122668
-
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies
-
Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol. 2008; 15:3866-3871.
-
(2008)
Can J Urol.
, vol.15
, pp. 3866-3871
-
-
Haas, G.P.1
Delongchamps, N.2
Brawley, O.W.3
Wang, C.Y.4
de la Roza, G.5
-
2
-
-
0001189211
-
Studies on prostatic cancer II. The effects of castration on advanced carcinoma of the prostate
-
Huggins C, Stevens RE, Hodges CV. Studies on prostatic cancer II. The effects of castration on advanced carcinoma of the prostate. Arch Surg. 1941; 43:209-223.
-
(1941)
Arch Surg.
, vol.43
, pp. 209-223
-
-
Huggins, C.1
Stevens, R.E.2
Hodges, C.V.3
-
3
-
-
0015370976
-
Studies on prostatic cancer I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate
-
Huggins C, Hodges CV. Studies on prostatic cancer I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin. 1972; 22:232-240.
-
(1972)
CA Cancer J Clin.
, vol.22
, pp. 232-240
-
-
Huggins, C.1
Hodges, C.V.2
-
4
-
-
33646005781
-
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
-
Caraglia M, Santini D, Marra M, Vincenzi B, Tonini G, Budillon A. Emerging anti-cancer molecular mechanisms of aminobisphosphonates. Endocr Relat Cancer. 2006; 13:7-26.
-
(2006)
Endocr Relat Cancer.
, vol.13
, pp. 7-26
-
-
Caraglia, M.1
Santini, D.2
Marra, M.3
Vincenzi, B.4
Tonini, G.5
Budillon, A.6
-
5
-
-
84919363339
-
Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer
-
Stachnik A, Yuen T, Iqbal J, Sgobba M, Gupta Y, Lu P, Colaianni G, Ji Y, Zhu LL, Kim SM, Li J, Liu P, Izadmehr S, et al. Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer. Proc Natl Acad Sci USA. 2014; 111:17995-8000.
-
(2014)
Proc Natl Acad Sci USA.
, vol.111
, pp. 17995-18000
-
-
Stachnik, A.1
Yuen, T.2
Iqbal, J.3
Sgobba, M.4
Gupta, Y.5
Lu, P.6
Colaianni, G.7
Ji, Y.8
Zhu, L.L.9
Kim, S.M.10
Li, J.11
Liu, P.12
Izadmehr, S.13
-
6
-
-
84919360515
-
Bisphosphonates inactivate human EGFRs to exert antitumor actions
-
Yuen T, Stachnik A, Iqbal J, Sgobba M, Gupta Y, Lu P, Colaianni G, Ji Y, Zhu LL, Kim SM, Li J, Liu P, Izadmehr S, et al. Bisphosphonates inactivate human EGFRs to exert antitumor actions. Proc Natl Acad of Sci USA. 2014; 111:17989-17994.
-
(2014)
Proc Natl Acad of Sci USA.
, vol.111
, pp. 17989-17994
-
-
Yuen, T.1
Stachnik, A.2
Iqbal, J.3
Sgobba, M.4
Gupta, Y.5
Lu, P.6
Colaianni, G.7
Ji, Y.8
Zhu, L.L.9
Kim, S.M.10
Li, J.11
Liu, P.12
Izadmehr, S.13
-
7
-
-
73449128342
-
The bisphosphonate zoledronic acid has anti-myeloma activity in vivo by inhibition of protein prenylation
-
Guenther A, Gordon S, Tiemann M, Burger R, Bakker F, Green JR, Baum W, Roelofs AJ, Rogers MJ, Gramatzki M. The bisphosphonate zoledronic acid has anti-myeloma activity in vivo by inhibition of protein prenylation. Int J Cancer. 2010; 126:239-246.
-
(2010)
Int J Cancer.
, vol.126
, pp. 239-246
-
-
Guenther, A.1
Gordon, S.2
Tiemann, M.3
Burger, R.4
Bakker, F.5
Green, J.R.6
Baum, W.7
Roelofs, A.J.8
Rogers, M.J.9
Gramatzki, M.10
-
8
-
-
84863317657
-
Novel aspects of mevalonate pathway inhibitors as antitumor agents
-
Thurnher M, Nussbaumer O, Gruenbacher G. Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin Cancer Res. 2012; 18:3524-3531.
-
(2012)
Clin Cancer Res.
, vol.18
, pp. 3524-3531
-
-
Thurnher, M.1
Nussbaumer, O.2
Gruenbacher, G.3
-
9
-
-
84879378840
-
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
-
Milone MR, Pucci B, Bruzzese F, Carbone C, Piro G, Costantini S, Capone F, Leone A, Di Gennaro E, Caraglia M, Budillon A. Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells. Cell Death Dis. 2013; 4:e641.
-
(2013)
Cell Death Dis.
, vol.4
, pp. e641
-
-
Milone, M.R.1
Pucci, B.2
Bruzzese, F.3
Carbone, C.4
Piro, G.5
Costantini, S.6
Capone, F.7
Leone, A.8
Di Gennaro, E.9
Caraglia, M.10
Budillon, A.11
-
10
-
-
84925013613
-
Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype
-
Milone MR, Pucci B, Bifulco K, Iannelli F, Lombardi R, Ciardiello C, Bruzzese F, Carriero MV, Budillon A. Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype. Oncotarget. 2014; 6:5324-5341.
-
(2014)
Oncotarget.
, vol.6
, pp. 5324-5341
-
-
Milone, M.R.1
Pucci, B.2
Bifulco, K.3
Iannelli, F.4
Lombardi, R.5
Ciardiello, C.6
Bruzzese, F.7
Carriero, M.V.8
Budillon, A.9
-
12
-
-
77954578642
-
Role of annexin A1 in mouse myoblast cell differentiation
-
Bizzarro V, Fontanella B, Franceschelli S, Pirozzi M, Christian H, Parente L, Petrella A. Role of annexin A1 in mouse myoblast cell differentiation. J Cell Physiol. 2010; 224:757-765.
-
(2010)
J Cell Physiol.
, vol.224
, pp. 757-765
-
-
Bizzarro, V.1
Fontanella, B.2
Franceschelli, S.3
Pirozzi, M.4
Christian, H.5
Parente, L.6
Petrella, A.7
-
13
-
-
84860485828
-
Annexin A1: novel roles in skeletal muscle biology
-
Bizzarro V, Petrella A, Parente L. Annexin A1: novel roles in skeletal muscle biology. J Cell Physiol. 2012; 227:3007-3015.
-
(2012)
J Cell Physiol.
, vol.227
, pp. 3007-3015
-
-
Bizzarro, V.1
Petrella, A.2
Parente, L.3
-
14
-
-
84866707827
-
Annexin A1 N-terminal derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions
-
Bizzarro V, Fontanella B, Carratù A, Belvedere R, Marfella R, Parente L, Petrella A. Annexin A1 N-terminal derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions. PLoS One. 2012; 7:e45639.
-
(2012)
PLoS One.
, vol.7
-
-
Bizzarro, V.1
Fontanella, B.2
Carratù, A.3
Belvedere, R.4
Marfella, R.5
Parente, L.6
Petrella, A.7
-
15
-
-
84868152138
-
Annexin A1 induces skeletal muscle cell migration acting through formyl peptide receptors
-
Bizzarro V, Belvedere R, Dal Piaz F, Parente L, Petrella A. Annexin A1 induces skeletal muscle cell migration acting through formyl peptide receptors. PLoS One. 2012; 7:e48246.
-
(2012)
PLoS One.
, vol.7
-
-
Bizzarro, V.1
Belvedere, R.2
Dal Piaz, F.3
Parente, L.4
Petrella, A.5
-
16
-
-
84887300751
-
Potential role of anxa1 in cancer
-
Guo C, Liu S, Sun MZ. Potential role of anxa1 in cancer. Future Oncol. 2013; 9:1773-1793.
-
(2013)
Future Oncol.
, vol.9
, pp. 1773-1793
-
-
Guo, C.1
Liu, S.2
Sun, M.Z.3
-
17
-
-
33745822755
-
Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors
-
Babbin BA, Lee WY, Parkos CA, Winfree LM. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem. 2006; 281:19588-19599.
-
(2006)
J Biol Chem.
, vol.281
, pp. 19588-19599
-
-
Babbin, B.A.1
Lee, W.Y.2
Parkos, C.A.3
Winfree, L.M.4
-
18
-
-
70449601776
-
Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice
-
Yi M, Schnitzer JE. Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc Natl Acad Sci USA. 2009; 106:17886-17891.
-
(2009)
Proc Natl Acad Sci USA.
, vol.106
, pp. 17886-17891
-
-
Yi, M.1
Schnitzer, J.E.2
-
19
-
-
80052854250
-
Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1
-
Yang Y, Liu Y, Yao X, Ping Y, Jiang T, Liu Q, Xu S, Huang J, Mou H, Gong W, Chen K, Bian X, Wang JM. Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. Am J Pathol. 2011; 179:1504-1512.
-
(2011)
Am J Pathol.
, vol.179
, pp. 1504-1512
-
-
Yang, Y.1
Liu, Y.2
Yao, X.3
Ping, Y.4
Jiang, T.5
Liu, Q.6
Xu, S.7
Huang, J.8
Mou, H.9
Gong, W.10
Chen, K.11
Bian, X.12
Wang, J.M.13
-
20
-
-
33745769758
-
Annexin-1 down-regulation in thyroid cancer correlates to the degree of tumor differentiation
-
Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E, Parente L. Annexin-1 down-regulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther. 2006; 5:643-647.
-
(2006)
Cancer Biol Ther.
, vol.5
, pp. 643-647
-
-
Petrella, A.1
Festa, M.2
Ercolino, S.F.3
Zerilli, M.4
Stassi, G.5
Solito, E.6
Parente, L.7
-
21
-
-
84863073621
-
Clinical significance of annexin A1 expression in breast cancer
-
Yom CK, Han W, Kim SW, Kim HS, Shin HC, Chang JN, Koo M, Noh DY, Moon BI. Clinical significance of annexin A1 expression in breast cancer. J Breast Cancer. 2011; 14:262-268.
-
(2011)
J Breast Cancer.
, vol.14
, pp. 262-268
-
-
Yom, C.K.1
Han, W.2
Kim, S.W.3
Kim, H.S.4
Shin, H.C.5
Chang, J.N.6
Koo, M.7
Noh, D.Y.8
Moon, B.I.9
-
22
-
-
0035881732
-
Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer
-
Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF Jr, Hampton GM. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001; 61:5974-5978.
-
(2001)
Cancer Res.
, vol.61
, pp. 5974-5978
-
-
Welsh, J.B.1
Sapinoso, L.M.2
Su, A.I.3
Kern, S.G.4
Wang-Rodriguez, J.5
Moskaluk, C.A.6
Frierson, H.F.7
Hampton, G.M.8
-
23
-
-
0036682002
-
Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease
-
LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002; 62:4499-4506.
-
(2002)
Cancer Res.
, vol.62
, pp. 4499-4506
-
-
LaTulippe, E.1
Satagopan, J.2
Smith, A.3
Scher, H.4
Scardino, P.5
Reuter, V.6
Gerald, W.L.7
-
24
-
-
19044391072
-
Gene expression correlates of clinical prostate cancer behavior
-
Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002; 1:203-209.
-
(2002)
Cancer Cell.
, vol.1
, pp. 203-209
-
-
Singh, D.1
Febbo, P.G.2
Ross, K.3
Jackson, D.G.4
Manola, J.5
Ladd, C.6
Tamayo, P.7
Renshaw, A.A.8
D'Amico, A.V.9
Richie, J.P.10
Lander, E.S.11
Loda, M.12
Kantoff, P.W.13
-
25
-
-
77249119762
-
The landscape of somatic copy-number alteration across human cancers
-
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010; 463:899-905.
-
(2010)
Nature.
, vol.463
, pp. 899-905
-
-
Beroukhim, R.1
Mermel, C.H.2
Porter, D.3
Wei, G.4
Raychaudhuri, S.5
Donovan, J.6
Barretina, J.7
Boehm, J.S.8
Dobson, J.9
Urashima, M.10
Mc Henry, K.T.11
Pinchback, R.M.12
Ligon, A.H.13
-
26
-
-
0036154940
-
Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer
-
Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res. 2002; 8:117-123.
-
(2002)
Clin Cancer Res.
, vol.8
, pp. 117-123
-
-
Kang, J.S.1
Calvo, B.F.2
Maygarden, S.J.3
Caskey, L.S.4
Mohler, J.L.5
Ornstein, D.K.6
-
27
-
-
28844443606
-
Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia
-
Patton KT, Chen HM, Joseph L, Yang XJ. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology. 2005; 47:597-601.
-
(2005)
Histopathology.
, vol.47
, pp. 597-601
-
-
Patton, K.T.1
Chen, H.M.2
Joseph, L.3
Yang, X.J.4
-
28
-
-
9144251970
-
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
-
Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA. 2004; 101:811-816.
-
(2004)
Proc Natl Acad Sci USA.
, vol.101
, pp. 811-816
-
-
Lapointe, J.1
Li, C.2
Higgins, J.P.3
van de Rijn, M.4
Bair, E.5
Montgomery, K.6
Ferrari, M.7
Egevad, L.8
Rayford, W.9
Bergerheim, U.10
Ekman, P.11
DeMarzo, A.M.12
Tibshirani, R.13
-
29
-
-
33845884027
-
Integrative molecular concept modeling of prostate cancer progression
-
Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM. Integrative molecular concept modeling of prostate cancer progression. Nat Genet. 2007; 39:41-51.
-
(2007)
Nat Genet.
, vol.39
, pp. 41-51
-
-
Tomlins, S.A.1
Mehra, R.2
Rhodes, D.R.3
Cao, X.4
Wang, L.5
Dhanasekaran, S.M.6
Kalyana-Sundaram, S.7
Wei, J.T.8
Rubin, M.A.9
Pienta, K.J.10
Shah, R.B.11
Chinnaiyan, A.M.12
-
30
-
-
77954255681
-
Integrative genomic profiling of human prostate cancer
-
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18:11-22.
-
(2010)
Cancer Cell.
, vol.18
, pp. 11-22
-
-
Taylor, B.S.1
Schultz, N.2
Hieronymus, H.3
Gopalan, A.4
Xiao, Y.5
Carver, B.S.6
Arora, V.K.7
Kaushik, P.8
Cerami, E.9
Reva, B.10
Antipin, Y.11
Mitsiades, N.12
Landers, T.13
-
31
-
-
84863723010
-
The mutational landscape of lethal castration-resistant prostate cancer
-
Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012; 487:239-243.
-
(2012)
Nature.
, vol.487
, pp. 239-243
-
-
Grasso, C.S.1
Wu, Y.M.2
Robinson, D.R.3
Cao, X.4
Dhanasekaran, S.M.5
Khan, A.P.6
Quist, M.J.7
Jing, X.8
Lonigro, R.J.9
Brenner, J.C.10
Asangani, I.A.11
Ateeq, B.12
Chun, S.Y.13
-
32
-
-
0347201147
-
Multiclass cancer diagnosis using tumor gene expression signatures
-
Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA. 2001; 98:15149-15154.
-
(2001)
Proc Natl Acad Sci USA.
, vol.98
, pp. 15149-15154
-
-
Ramaswamy, S.1
Tamayo, P.2
Rifkin, R.3
Mukherjee, S.4
Yeang, C.H.5
Angelo, M.6
Ladd, C.7
Reich, M.8
Latulippe, E.9
Mesirov, J.P.10
Poggio, T.11
Gerald, W.12
Loda, M.13
-
33
-
-
1542574202
-
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgenresponsive genes and mechanisms of therapy resistance
-
Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V, Gerald WL. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgenresponsive genes and mechanisms of therapy resistance. Am J Pathol. 2004; 164:217-227.
-
(2004)
Am J Pathol.
, vol.164
, pp. 217-227
-
-
Holzbeierlein, J.1
Lal, P.2
LaTulippe, E.3
Smith, A.4
Satagopan, J.5
Zhang, L.6
Ryan, C.7
Smith, S.8
Scher, H.9
Scardino, P.10
Reuter, V.11
Gerald, W.L.12
-
34
-
-
84924931347
-
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
-
Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell. 2005; 7:1011-1019.
-
(2005)
Cancer Cell.
, vol.7
, pp. 1011-1019
-
-
Varambally, S.1
Yu, J.2
Laxman, B.3
Rhodes, D.R.4
Mehra, R.5
Tomlins, S.A.6
Shah, R.B.7
Chandran, U.8
Monzon, F.A.9
Becich, M.J.10
Wei, J.T.11
Pienta, K.J.12
Ghosh, D.13
-
35
-
-
44949204525
-
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
-
Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andrén O, Johnson LA, Tang J, Adami HO, Calza S, et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst. 2008; 100:815-825.
-
(2008)
J Natl Cancer Inst.
, vol.100
, pp. 815-825
-
-
Setlur, S.R.1
Mertz, K.D.2
Hoshida, Y.3
Demichelis, F.4
Lupien, M.5
Perner, S.6
Sboner, A.7
Pawitan, Y.8
Andrén, O.9
Johnson, L.A.10
Tang, J.11
Adami, H.O.12
Calza, S.13
-
36
-
-
77955449641
-
Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model
-
Zhang J, Wang L, Anderson LB, Witthuhn B, Xu Y, Lu J. Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model. Cancer Prev Res. 2010; 3:994-1006.
-
(2010)
Cancer Prev Res.
, vol.3
, pp. 994-1006
-
-
Zhang, J.1
Wang, L.2
Anderson, L.B.3
Witthuhn, B.4
Xu, Y.5
Lu, J.6
-
37
-
-
33947678705
-
Annexin 1: the new face of an old molecule
-
Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J. 2007; 21:968-975.
-
(2007)
FASEB J.
, vol.21
, pp. 968-975
-
-
Lim, L.H.1
Pervaiz, S.2
-
38
-
-
68549097911
-
The annexins: Spatial and temporal coordination of signaling events during cellular stress
-
Monastyrskaya K, Babiychuk EB, Draeger A. The annexins: Spatial and temporal coordination of signaling events during cellular stress. Cell Mol Life Sci. 2009; 66:2623-2642.
-
(2009)
Cell Mol Life Sci.
, vol.66
, pp. 2623-2642
-
-
Monastyrskaya, K.1
Babiychuk, E.B.2
Draeger, A.3
-
40
-
-
84925439444
-
Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells
-
Belvedere R, Bizzarro V, Popolo A, Dal Piaz F, Vasaturo M, Picardi P, Parente L, Petrella A. Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells. BMC Cancer. 2014; 14:961.
-
(2014)
BMC Cancer.
, vol.14
, pp. 961
-
-
Belvedere, R.1
Bizzarro, V.2
Popolo, A.3
Dal Piaz, F.4
Vasaturo, M.5
Picardi, P.6
Parente, L.7
Petrella, A.8
-
41
-
-
67649438808
-
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family
-
Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev. 2009; 61:119-161.
-
(2009)
Pharmacol Rev.
, vol.61
, pp. 119-161
-
-
Ye, R.D.1
Boulay, F.2
Wang, J.M.3
Dahlgren, C.4
Gerard, C.5
Parmentier, M.6
Serhan, C.N.7
Murphy, P.M.8
-
42
-
-
53149147403
-
The role of annexins in tumour development and progression
-
Mussunoor S, Murray GI. The role of annexins in tumour development and progression. J Pathol. 2008; 216:131-140.
-
(2008)
J Pathol.
, vol.216
, pp. 131-140
-
-
Mussunoor, S.1
Murray, G.I.2
-
44
-
-
23844518057
-
Biochemistry and biomechanics of cell motility
-
Li S, Guan JL, Chien S. Biochemistry and biomechanics of cell motility. Annu Rev Biomed. 2005; 7:105-150.
-
(2005)
Annu Rev Biomed.
, vol.7
, pp. 105-150
-
-
Li, S.1
Guan, J.L.2
Chien, S.3
-
45
-
-
77956178360
-
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
-
Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010; 29:4741-4751.
-
(2010)
Oncogene.
, vol.29
, pp. 4741-4751
-
-
Singh, A.1
Settleman, J.2
-
46
-
-
77950903213
-
Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells
-
de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J, Pardali E, Le Dévédec SE, Smit VT, van der Wal A, Van't Veer LJ, Cleton-Jansen AM, ten Dijke P, et al. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci USA. 2010; 107:6340-6345.
-
(2010)
Proc Natl Acad Sci USA.
, vol.107
, pp. 6340-6345
-
-
de Graauw, M.1
van Miltenburg, M.H.2
Schmidt, M.K.3
Pont, C.4
Lalai, R.5
Kartopawiro, J.6
Pardali, E.7
Le Dévédec, S.E.8
Smit, V.T.9
van der Wal, A.10
Van't Veer, L.J.11
Cleton-Jansen, A.M.12
ten Dijke, P.13
-
48
-
-
67349156673
-
Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
-
Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB, Farrar WL. Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis. 2009; 26:433-446.
-
(2009)
Clin Exp Metastasis.
, vol.26
, pp. 433-446
-
-
Klarmann, G.J.1
Hurt, E.M.2
Mathews, L.A.3
Zhang, X.4
Duhagon, M.A.5
Mistree, T.6
Thomas, S.B.7
Farrar, W.L.8
-
49
-
-
84855484465
-
Molecular classification of prostate cancer using curated expression signatures
-
Markert EK, Mizuno H, Vazquez A, Levine AJ. Molecular classification of prostate cancer using curated expression signatures. Proc Natl Acad Sci USA. 2011; 108:21276-21281.
-
(2011)
Proc Natl Acad Sci USA.
, vol.108
, pp. 21276-21281
-
-
Markert, E.K.1
Mizuno, H.2
Vazquez, A.3
Levine, A.J.4
-
50
-
-
85027923138
-
Nanog promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
-
Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, Repass J, Zaehres H, Shen JJ, Tang DG. Nanog promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 2011; 30:3833-3845.
-
(2011)
Oncogene.
, vol.30
, pp. 3833-3845
-
-
Jeter, C.R.1
Liu, B.2
Liu, X.3
Chen, X.4
Liu, C.5
Calhoun-Davis, T.6
Repass, J.7
Zaehres, H.8
Shen, J.J.9
Tang, D.G.10
-
51
-
-
84857572466
-
Frequent gene products and molecular pathways altered in prostate cancer-and metastasis-initiating cells and their progenies and novel promising multi targeted therapies
-
Mimeault M, Batra SK. Frequent gene products and molecular pathways altered in prostate cancer-and metastasis-initiating cells and their progenies and novel promising multi targeted therapies. Mol Med. 2011; 17:949-964.
-
(2011)
Mol Med.
, vol.17
, pp. 949-964
-
-
Mimeault, M.1
Batra, S.K.2
-
52
-
-
39449090031
-
CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
-
Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer. 2008; 98:756-765.
-
(2008)
Br J Cancer.
, vol.98
, pp. 756-765
-
-
Hurt, E.M.1
Kawasaki, B.T.2
Klarmann, G.J.3
Thomas, S.B.4
Farrar, W.L.5
-
53
-
-
78751569615
-
Prostate cancer stem cells: do they have a basal or luminal phenotype?
-
Maitland NJ, Frame FM, Polson ES, Lewis JL, Collins AT. Prostate cancer stem cells: do they have a basal or luminal phenotype? Horm Cancer. 2011; 2:47-61.
-
(2011)
Horm Cancer.
, vol.2
, pp. 47-61
-
-
Maitland, N.J.1
Frame, F.M.2
Polson, E.S.3
Lewis, J.L.4
Collins, A.T.5
-
54
-
-
82355169941
-
The aldehyde dehydrogenase enzyme 7a1 is functionally involved in prostate cancer bone metastasis
-
van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger RC, van der Pluijm G. The aldehyde dehydrogenase enzyme 7a1 is functionally involved in prostate cancer bone metastasis. Clin Exp Metastasis. 2011; 28:615-625.
-
(2011)
Clin Exp Metastasis.
, vol.28
, pp. 615-625
-
-
van den Hoogen, C.1
van der Horst, G.2
Cheung, H.3
Buijs, J.T.4
Pelger, R.C.5
van der Pluijm, G.6
-
55
-
-
28244472369
-
Prospective identification of tumorigenic prostate cancer stem cells
-
Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005; 65:10946-10951.
-
(2005)
Cancer Res.
, vol.65
, pp. 10946-10951
-
-
Collins, A.T.1
Berry, P.A.2
Hyde, C.3
Stower, M.J.4
Maitland, N.J.5
-
56
-
-
33645026803
-
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells
-
Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 2006; 25:1696-1708.
-
(2006)
Oncogene.
, vol.25
, pp. 1696-1708
-
-
Patrawala, L.1
Calhoun, T.2
Schneider-Broussard, R.3
Li, H.4
Bhatia, B.5
Tang, S.6
Reilly, J.G.7
Chandra, D.8
Zhou, J.9
Claypool, K.10
Coghlan, L.11
Tang, D.G.12
-
57
-
-
47149102561
-
Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions
-
Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH, Berry PA, Hyde CF, Lewis JL, Stower MJ, Maitland NJ, Collins AT. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol. 2008; 9:R83.
-
(2008)
Genome Biol.
, vol.9
, pp. R83
-
-
Birnie, R.1
Bryce, S.D.2
Roome, C.3
Dussupt, V.4
Droop, A.5
Lang, S.H.6
Berry, P.A.7
Hyde, C.F.8
Lewis, J.L.9
Stower, M.J.10
Maitland, N.J.11
Collins, A.T.12
-
58
-
-
78751623400
-
Tumour-initiating stem-like cells in human prostate cancer exhibit increased nf-kappab signalling
-
Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI. Tumour-initiating stem-like cells in human prostate cancer exhibit increased nf-kappab signalling. Nat Commun. 2011; 2:162.
-
(2011)
Nat Commun.
, vol.2
, pp. 162
-
-
Rajasekhar, V.K.1
Studer, L.2
Gerald, W.3
Socci, N.D.4
Scher, H.I.5
-
59
-
-
84859416889
-
Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells
-
Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, Gleave M, Wu H. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res. 2012; 72:1878-1875.
-
(2012)
Cancer Res.
, vol.72
, pp. 1875-1878
-
-
Mulholland, D.J.1
Kobayashi, N.2
Ruscetti, M.3
Zhi, A.4
Tran, L.M.5
Huang, J.6
Gleave, M.7
Wu, H.8
-
60
-
-
47749116454
-
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
-
Bourguignon LY, Peyrollier K, Xia W, Gilad E. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem. 2008; 283:17635-17651.
-
(2008)
J Biol Chem.
, vol.283
, pp. 17635-17651
-
-
Bourguignon, L.Y.1
Peyrollier, K.2
Xia, W.3
Gilad, E.4
-
62
-
-
0035872426
-
Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation
-
Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res. 2001; 61:4222-4228.
-
(2001)
Cancer Res.
, vol.61
, pp. 4222-4228
-
-
Ellenrieder, V.1
Hendler, S.F.2
Boeck, W.3
Seufferlein, T.4
Menke, A.5
Ruhland, C.6
Adler, G.7
Gress, T.M.8
-
63
-
-
78651454089
-
EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling
-
Chang CJ, Yang JY, Xia W, Chen CT, Xie X, Chao CH, Woodward WA, Hsu JM, Hortobagyi GN, Hung MC. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell. 19:86-100.
-
Cancer Cell
, vol.19
, pp. 86-100
-
-
Chang, C.J.1
Yang, J.Y.2
Xia, W.3
Chen, C.T.4
Xie, X.5
Chao, C.H.6
Woodward, W.A.7
Hsu, J.M.8
Hortobagyi, G.N.9
Hung, M.C.10
-
64
-
-
0036364467
-
Multidrug resistance in cancer: role of ATP-dependent transporters
-
Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002; 2:48-58.
-
(2002)
Nat Rev Cancer.
, vol.2
, pp. 48-58
-
-
Gottesman, M.M.1
Fojo, T.2
Bates, S.E.3
-
65
-
-
0344858049
-
Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines
-
Laurencot CM, Scheffer GL, Scheper RJ, Shoemaker RH. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int J Cancer. 1997; 72:1021-1026.
-
(1997)
Int J Cancer.
, vol.72
, pp. 1021-1026
-
-
Laurencot, C.M.1
Scheffer, G.L.2
Scheper, R.J.3
Shoemaker, R.H.4
-
66
-
-
78751676408
-
Cells of origin in cancer
-
Visvader JE. Cells of origin in cancer. Nature. 2011; 469:314-322.
-
(2011)
Nature.
, vol.469
, pp. 314-322
-
-
Visvader, J.E.1
-
67
-
-
84873566048
-
The roots of cancer: stem cells and the basis for tumor heterogeneity
-
Shibata M, Shen MM. The roots of cancer: stem cells and the basis for tumor heterogeneity. Bioessays. 2013; 35:253-260.
-
(2013)
Bioessays.
, vol.35
, pp. 253-260
-
-
Shibata, M.1
Shen, M.M.2
-
68
-
-
0023102072
-
Cytokeratin characterization of human prostatic carcinoma and its derived cell lines
-
Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Celniker A. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res. 1987; 47:281-286.
-
(1987)
Cancer Res.
, vol.47
, pp. 281-286
-
-
Nagle, R.B.1
Ahmann, F.R.2
McDaniel, K.M.3
Paquin, M.L.4
Clark, V.A.5
Celniker, A.6
-
69
-
-
0026672669
-
Keratin profiles in normal/hyperplastic prostates and prostate carcinoma
-
Okada H, Tsubura A, Okamura A, Senzaki H, Naka Y, Komatz Y, Morii S. Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch A Pathol Anat Histopathol. 1992; 421:157-161.
-
(1992)
Virchows Arch A Pathol Anat Histopathol.
, vol.421
, pp. 157-161
-
-
Okada, H.1
Tsubura, A.2
Okamura, A.3
Senzaki, H.4
Naka, Y.5
Komatz, Y.6
Morii, S.7
-
70
-
-
0025290840
-
Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland
-
O'Malley FP, Grignon DJ, Shum DT. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland. Virchows Arch A Pathol Anat Histopathol. 1990; 417:191-196.
-
(1990)
Virchows Arch A Pathol Anat Histopathol.
, vol.417
, pp. 191-196
-
-
O'Malley, F.P.1
Grignon, D.J.2
Shum, D.T.3
-
71
-
-
0242691894
-
Cellular and molecular biology of the prostate: stem cell biology
-
Schalken JA, van Leenders G. Cellular and molecular biology of the prostate: stem cell biology. Urology. 2003; 62:11-20.
-
(2003)
Urology.
, vol.62
, pp. 11-20
-
-
Schalken, J.A.1
van Leenders, G.2
-
72
-
-
70349438989
-
A luminal epithelial stem cell that is a cell of origin for prostate cancer
-
Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C, Shen MM. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature. 2009; 461:495-500.
-
(2009)
Nature.
, vol.461
, pp. 495-500
-
-
Wang, X.1
Kruithof-de Julio, M.2
Economides, K.D.3
Walker, D.4
Yu, H.5
Halili, M.V.6
Hu, Y.P.7
Price, S.M.8
Abate-Shen, C.9
Shen, M.M.10
-
73
-
-
77249178726
-
Basal epithelial stem cells are efficient targets for prostate cancer initiation
-
Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA. 2010; 107:2610-2615.
-
(2010)
Proc Natl Acad Sci USA.
, vol.107
, pp. 2610-2615
-
-
Lawson, D.A.1
Zong, Y.2
Memarzadeh, S.3
Xin, L.4
Huang, J.5
Witte, O.N.6
-
74
-
-
31944448885
-
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation
-
Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA. 2006; 103:1480-1485.
-
(2006)
Proc Natl Acad Sci USA.
, vol.103
, pp. 1480-1485
-
-
Wang, S.1
Garcia, A.J.2
Wu, M.3
Lawson, D.A.4
Witte, O.N.5
Wu, H.6
-
75
-
-
77955121375
-
Identification of a cell of origin for human prostate cancer
-
Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science. 2010; 329:568-571.
-
(2010)
Science.
, vol.329
, pp. 568-571
-
-
Goldstein, A.S.1
Huang, J.2
Guo, C.3
Garraway, I.P.4
Witte, O.N.5
-
76
-
-
0035663808
-
Expression of basal cell keratins in human prostate cancer metastases and cell lines
-
Van Leenders GJ, Aalders TW, Hulsbergen-Van De Kaa CA, Ruiter DJ, Schalken JA. Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol. 2001; 195:563-570.
-
(2001)
J Pathol.
, vol.195
, pp. 563-570
-
-
Van Leenders, G.J.1
Aalders, T.W.2
Hulsbergen-Van De Kaa, C.A.3
Ruiter, D.J.4
Schalken, J.A.5
-
77
-
-
33750948495
-
A comparative study of protein profiling by proteomic analysis in camptothecin-resistant PC3 and camptothecinsensitive LNCaP human prostate cancer cells
-
Hasegawa N, Mizutani K, Suzuki T, Deguchi T, Nozawa Y. A comparative study of protein profiling by proteomic analysis in camptothecin-resistant PC3 and camptothecinsensitive LNCaP human prostate cancer cells. Urol Int. 2006; 77:347-354.
-
(2006)
Urol Int.
, vol.77
, pp. 347-354
-
-
Hasegawa, N.1
Mizutani, K.2
Suzuki, T.3
Deguchi, T.4
Nozawa, Y.5
-
78
-
-
21644438696
-
Localization of annexins I, II, IV, and VII in whole prostate sections from radical prostatectomy patients
-
Lehnigk U, Zimmermann U, Woenckhaus C, Giebel J. Localization of annexins I, II, IV, and VII in whole prostate sections from radical prostatectomy patients. Histol Histopathol. 2005; 20:673-680.
-
(2005)
Histol Histopathol.
, vol.20
, pp. 673-680
-
-
Lehnigk, U.1
Zimmermann, U.2
Woenckhaus, C.3
Giebel, J.4
-
79
-
-
67650151006
-
Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling
-
Inokuchi J, Lau A, Tyson DR, Ornstein DK. Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling. Carcinogenesis. 2009; 30:1082-1088.
-
(2009)
Carcinogenesis.
, vol.30
, pp. 1082-1088
-
-
Inokuchi, J.1
Lau, A.2
Tyson, D.R.3
Ornstein, D.K.4
-
80
-
-
0031849012
-
Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study
-
Dreier R, Schmid KW, Gerke V, Riehemann K. Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem Cell Biol. 1998; 110:137-148.
-
(1998)
Histochem Cell Biol.
, vol.110
, pp. 137-148
-
-
Dreier, R.1
Schmid, K.W.2
Gerke, V.3
Riehemann, K.4
-
81
-
-
0037372244
-
Evidence for a role of the adenosine 5'-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculostellate cells
-
Chapman LP, Epton MJ, Buckingham JC, Morris JF, Christian HC. Evidence for a role of the adenosine 5'-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculostellate cells. Endocrinology. 2003; 144:1062-1073.
-
(2003)
Endocrinology.
, vol.144
, pp. 1062-1073
-
-
Chapman, L.P.1
Epton, M.J.2
Buckingham, J.C.3
Morris, J.F.4
Christian, H.C.5
-
82
-
-
1542270316
-
Mediation of annexin 1 secretion by a probenecid-sensitive ABC-transporter in rat inflamed mucosa
-
Wein S, Fauroux M, Laffitte J, de Nadai P, Guaini C, Pons F. Mediation of annexin 1 secretion by a probenecid-sensitive ABC-transporter in rat inflamed mucosa. Biochem Pharmacol. 2004; 67:1195-1202.
-
(2004)
Biochem Pharmacol.
, vol.67
, pp. 1195-1202
-
-
Wein, S.1
Fauroux, M.2
Laffitte, J.3
de Nadai, P.4
Guaini, C.5
Pons, F.6
-
83
-
-
34047195135
-
Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells
-
Ni J, Pang ST, Yeh S. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells. Prostate. 2007; 67:463-471.
-
(2007)
Prostate.
, vol.67
, pp. 463-471
-
-
Ni, J.1
Pang, S.T.2
Yeh, S.3
-
84
-
-
67649610425
-
Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells
-
Coffelt SB, Tomchuck SL, Zwezdaryk KJ, Danka ES, Scandurro AB. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Mol Cancer Res. 2009; 7:907-915.
-
(2009)
Mol Cancer Res.
, vol.7
, pp. 907-915
-
-
Coffelt, S.B.1
Tomchuck, S.L.2
Zwezdaryk, K.J.3
Danka, E.S.4
Scandurro, A.B.5
-
85
-
-
84916604809
-
Inflammation and Cancer: Role of Annexin A1 and FPR2/ALX in Proliferation and Metastasis in Human Laryngeal Squamous Cell Carcinoma
-
Gastardelo TS, Cunha BR, Raposo LS, Maniglia JV, Cury PM, Lisoni FC, Tajara EH, Oliani SM. Inflammation and Cancer: Role of Annexin A1 and FPR2/ALX in Proliferation and Metastasis in Human Laryngeal Squamous Cell Carcinoma. PLoS One. 2014; 9:e111317.
-
(2014)
PLoS One.
, vol.9
, pp. e111317
-
-
Gastardelo, T.S.1
Cunha, B.R.2
Raposo, L.S.3
Maniglia, J.V.4
Cury, P.M.5
Lisoni, F.C.6
Tajara, E.H.7
Oliani, S.M.8
-
86
-
-
79551645139
-
Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2
-
Khau T, Langenbach SY, Schuliga M, Harris T, Johnstone CN, Anderson RL, Stewart AG. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. FASEB J. 2011; 25:483-496.
-
(2011)
FASEB J.
, vol.25
, pp. 483-496
-
-
Khau, T.1
Langenbach, S.Y.2
Schuliga, M.3
Harris, T.4
Johnstone, C.N.5
Anderson, R.L.6
Stewart, A.G.7
-
87
-
-
84869506420
-
Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway
-
Cheng TY, Wu MS, Lin JT, Lin MT, Shun CT, Huang HY, Hua KT, Kuo ML. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway. Cancer. 2012; 118:5757-5767.
-
(2012)
Cancer.
, vol.118
, pp. 5757-5767
-
-
Cheng, T.Y.1
Wu, M.S.2
Lin, J.T.3
Lin, M.T.4
Shun, C.T.5
Huang, H.Y.6
Hua, K.T.7
Kuo, M.L.8
-
88
-
-
80051798505
-
NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells
-
Cattaneo F, Iaccio A, Guerra G, Montagnani S, Ammendola R. NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells. Free Radic Biol Med. 2011; 51:1126-1136.
-
(2011)
Free Radic Biol Med.
, vol.51
, pp. 1126-1136
-
-
Cattaneo, F.1
Iaccio, A.2
Guerra, G.3
Montagnani, S.4
Ammendola, R.5
-
89
-
-
84877765417
-
WKYMVm-induced cross-talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A
-
Cattaneo F, Parisi M, Ammendola R. WKYMVm-induced cross-talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A. FEBS Lett. 2013; 587:1536-1542.
-
(2013)
FEBS Lett.
, vol.587
, pp. 1536-1542
-
-
Cattaneo, F.1
Parisi, M.2
Ammendola, R.3
-
90
-
-
57649099275
-
FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblasts Arch Biochem Biophys
-
Iaccio A, Cattaneo F, Mauro M, Ammendola R. FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblasts Arch Biochem Biophys. 2009; 481:94-100.
-
(2009)
, vol.481
, pp. 94-100
-
-
Iaccio, A.1
Cattaneo, F.2
Mauro, M.3
Ammendola, R.4
-
91
-
-
78651286581
-
Expression and signaling of formyl peptide receptors in the brain
-
Cattaneo F, Guerra G, Ammendola R. Expression and signaling of formyl peptide receptors in the brain. Neurochem Res. 2010; 35:2018-2026.
-
(2010)
Neurochem Res.
, vol.35
, pp. 2018-2026
-
-
Cattaneo, F.1
Guerra, G.2
Ammendola, R.3
-
92
-
-
84954363411
-
Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment
-
[Epub ahead of print]
-
Sainz B Jr, Alcala S, Garcia E, Sanchez-Ripoll Y, Azevedo MM, Cioffi M, Tatari M, Miranda-Lorenzo I, Hidalgo M, Gomez-Lopez G, Cañamero M, Erkan M, Kleeff J, et al. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment. Gut. 2015; . doi: 10.1136/ gutjnl-2014-308935. [Epub ahead of print].
-
(2015)
Gut.
-
-
Sainz, B.1
Alcala, S.2
Garcia, E.3
Sanchez-Ripoll, Y.4
Azevedo, M.M.5
Cioffi, M.6
Tatari, M.7
Miranda-Lorenzo, I.8
Hidalgo, M.9
Gomez-Lopez, G.10
Cañamero, M.11
Erkan, M.12
Kleeff, J.13
-
93
-
-
33947650037
-
Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides
-
John CD, Sahni V, Mehet D, Morris JF, Christian HC, Perretti M, Flower RJ, Solito E, Buckingham JC. Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides. FASEB J. 2007; 21:1037-1046.
-
(2007)
FASEB J.
, vol.21
, pp. 1037-1046
-
-
John, C.D.1
Sahni, V.2
Mehet, D.3
Morris, J.F.4
Christian, H.C.5
Perretti, M.6
Flower, R.J.7
Solito, E.8
Buckingham, J.C.9
-
94
-
-
84899480372
-
CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features
-
Geary LA, Nash KA, Adisetiyo H, Liang M, Liao CP, Jeong JH, Zandi E, Roy-Burman P. CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features. Mol Cancer Res. 2014; 12:607-621.
-
(2014)
Mol Cancer Res.
, vol.12
, pp. 607-621
-
-
Geary, L.A.1
Nash, K.A.2
Adisetiyo, H.3
Liang, M.4
Liao, C.P.5
Jeong, J.H.6
Zandi, E.7
Roy-Burman, P.8
-
95
-
-
84899574120
-
Cancer stem cells and tumor metastasis
-
Li S, Li Q. Cancer stem cells and tumor metastasis. Int J Oncol. 2014; 44:1806-1812.
-
(2014)
Int J Oncol.
, vol.44
, pp. 1806-1812
-
-
Li, S.1
Li, Q.2
-
96
-
-
84881453720
-
Understanding and targeting cancer stem cells: therapeutic implications and challenges
-
Chen K, Huang YH, Chen JL. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin. 2013; 34:732-740.
-
(2013)
Acta Pharmacol Sin.
, vol.34
, pp. 732-740
-
-
Chen, K.1
Huang, Y.H.2
Chen, J.L.3
-
98
-
-
84874299107
-
New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells
-
Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, et al. New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. J Mol Cell Biol. 2013; 5:14-26.
-
(2013)
J Mol Cell Biol.
, vol.5
, pp. 14-26
-
-
Lee, S.O.1
Ma, Z.2
Yeh, C.R.3
Luo, J.4
Lin, T.H.5
Lai, K.P.6
Yamashita, S.7
Liang, L.8
Tian, J.9
Li, L.10
Jiang, Q.11
Huang, C.K.12
Niu, Y.13
-
99
-
-
70350212976
-
STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells
-
Sherry MM, Reeves A, Wu JK, Cochran BH. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells. 2009; 27:2383-2392.
-
(2009)
Stem Cells.
, vol.27
, pp. 2383-2392
-
-
Sherry, M.M.1
Reeves, A.2
Wu, J.K.3
Cochran, B.H.4
-
100
-
-
81155128494
-
Absolute requirement for STAT3 function in small-intestine crypt stem cell survival
-
Matthews JR, Sansom OJ, Clarke AR. Absolute requirement for STAT3 function in small-intestine crypt stem cell survival. Cell Death Differ. 2011; 18:1934-1943.
-
(2011)
Cell Death Differ.
, vol.18
, pp. 1934-1943
-
-
Matthews, J.R.1
Sansom, O.J.2
Clarke, A.R.3
-
101
-
-
84900865954
-
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
-
Abubaker K, Luwor RB, Zhu H, McNally O, Quinn MA, Burns CJ, Thompson EW, Findlay JK, Ahmed N. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. BMC Cancer. 2014; 14:317.
-
(2014)
BMC Cancer.
, vol.14
, pp. 317
-
-
Abubaker, K.1
Luwor, R.B.2
Zhu, H.3
McNally, O.4
Quinn, M.A.5
Burns, C.J.6
Thompson, E.W.7
Findlay, J.K.8
Ahmed, N.9
-
102
-
-
84898859312
-
The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
-
Bishop JL, Thaper D, Zoubeidi A. The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer. Cancers. 2014; 6:829-859.
-
(2014)
Cancers.
, vol.6
, pp. 829-859
-
-
Bishop, J.L.1
Thaper, D.2
Zoubeidi, A.3
-
103
-
-
77958099641
-
Multiple drug resistance mechanisms in cancer
-
Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol. 2010; 46:308-316.
-
(2010)
Mol Biotechnol.
, vol.46
, pp. 308-316
-
-
Baguley, B.C.1
-
104
-
-
84900871973
-
Regulatory mechanisms of annexin-induced chemotherapy resistance in cisplatin resistant lung adenocarcinoma
-
Wang C, Xiao Q, Li YW, Zhao C, Jia N, Li RL, Cao SS, Cui J, Wang L, Wu Y, Wen AD. Regulatory mechanisms of annexin-induced chemotherapy resistance in cisplatin resistant lung adenocarcinoma. Asian Pac J Cancer Prev. 2014; 15:3191-3194.
-
(2014)
Asian Pac J Cancer Prev.
, vol.15
, pp. 3191-3194
-
-
Wang, C.1
Xiao, Q.2
Li, Y.W.3
Zhao, C.4
Jia, N.5
Li, R.L.6
Cao, S.S.7
Cui, J.8
Wang, L.9
Wu, Y.10
Wen, A.D.11
-
105
-
-
79960450335
-
Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry
-
Yoshida K, Kuramitsu Y, Murakami K, Ryozawa S, Taba K, Kaino S, Zhang X, Sakaida I, Nakamura K. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Anticancer Res. 2011; 31:2103-2108.
-
(2011)
Anticancer Res.
, vol.31
, pp. 2103-2108
-
-
Yoshida, K.1
Kuramitsu, Y.2
Murakami, K.3
Ryozawa, S.4
Taba, K.5
Kaino, S.6
Zhang, X.7
Sakaida, I.8
Nakamura, K.9
-
106
-
-
78149405526
-
Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells
-
Lee DH, Chung K, Song JA, Kim TH, Kang H, Huh JH, Jung SG, Ko JJ, An HJ. Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells. J Proteome Res. 2010; 9:5668-5676.
-
(2010)
J Proteome Res.
, vol.9
, pp. 5668-5676
-
-
Lee, D.H.1
Chung, K.2
Song, J.A.3
Kim, T.H.4
Kang, H.5
Huh, J.H.6
Jung, S.G.7
Ko, J.J.8
An, H.J.9
-
107
-
-
84911466504
-
Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer
-
Yu S, Meng Q, Hu H, Zhang M. Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer. Int J Clin Exp Pathol. 2014; 7:5538-5548.
-
(2014)
Int J Clin Exp Pathol.
, vol.7
, pp. 5538-5548
-
-
Yu, S.1
Meng, Q.2
Hu, H.3
Zhang, M.4
-
108
-
-
79960440773
-
Identification of differentially expressed proteins in tumour necrosis factor-alpha-resistant and -sensitive rat hepatoma cells
-
Kuramitsu Y, Zhang X, Wang Y, Nakamura K. Identification of differentially expressed proteins in tumour necrosis factor-alpha-resistant and -sensitive rat hepatoma cells. Anticancer Res. 2011; 31:2059-2063.
-
(2011)
Anticancer Res.
, vol.31
, pp. 2059-2063
-
-
Kuramitsu, Y.1
Zhang, X.2
Wang, Y.3
Nakamura, K.4
-
109
-
-
84881484305
-
Identification of Annexin A1 interacting proteins in chronic myeloid leukemia KCL22 cells
-
Colavita I, Esposito N, Quintarelli C, Nigro E, Pane F, Ruoppolo M, Salvatore F. Identification of Annexin A1 interacting proteins in chronic myeloid leukemia KCL22 cells. Proteomics. 2013; 13:2414-2418.
-
(2013)
Proteomics.
, vol.13
, pp. 2414-2418
-
-
Colavita, I.1
Esposito, N.2
Quintarelli, C.3
Nigro, E.4
Pane, F.5
Ruoppolo, M.6
Salvatore, F.7
-
110
-
-
42549110070
-
Cl-IBMECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation
-
Morello S, Petrella A, Festa M, Popolo A, Monaco M, Vuttariello E, Chiappetta G, Parente L, Pinto A. Cl-IBMECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. Cancer Biol Ther. 2008; 7:278-84.
-
(2008)
Cancer Biol Ther.
, vol.7
, pp. 278-284
-
-
Morello, S.1
Petrella, A.2
Festa, M.3
Popolo, A.4
Monaco, M.5
Vuttariello, E.6
Chiappetta, G.7
Parente, L.8
Pinto, A.9
|